We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
In an Olink-sponsored Labroots webinar on February 4 three key opinion leaders in proteomics will discuss how integrating antibody-based methods with LC- MS ultimately can advance clinical research.
In the webinar Advancing proteomics in clinical research with the combined strengths of mass spectrometry and affinity-based methods KTH Professor in Translational Proteomics Jochen Schwenk, together with Professor of Pathology Hanno Steen from Harvard and Staff Scientist Metabolomics and Proteomics Core Ann-Christine König from Helmholtz Center Munich will discuss how the integration of proximity extension assay (PEA), with LC-MS can expand proteome coverage, facilitate biomarker discovery, and streamline the validation process.
The webinar will give the opportunity to engage with leading experts in the field and the topics include:
How does next-generation affinity-based proteomics dive into low-abundance proteins in plasma and serum to expand proteome coverage?
Which are the advantages and challenges of integrating affinity-based methods with LC-MS for comprehensive proteomic analysis?